---
title: "Runben Biotechnology (603193.SH) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/603193.SH/norm.md"
symbol: "603193.SH"
name: "Runben Biotechnology"
parent: "https://longbridge.com/en/quote/603193.SH.md"
datetime: "2026-03-17T22:57:18.295Z"
locales:
  - [en](https://longbridge.com/en/quote/603193.SH/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/603193.SH/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/603193.SH/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/603193.SH/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/603193.SH/norm.md)


# Runben Biotechnology (603193.SH) — Financial Reports

## Income Statement (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.1993 | 0.3466 | 0.1100 | 0.0983 | 0.1998 |
| ROE | 14.45% | 26.67% | 8.41% | 7.62% | 15.88% |
| Revenue | 342.41M | 655.08M | 240.03M | 280.66M | 293.49M |
| Net income | 78.52M | 143.33M | 44.20M | 39.28M | 80.86M |
| Operating income | 88.16M | 160.78M | 44.26M | 38.79M | 86.04M |
| Gross margin | 59.64% | 57.78% | 57.67% | 56.92% | 58.99% |
| Net margin | 22.93% | 21.88% | 18.41% | 13.99% | 27.55% |
| Profit quality | 101.67% | 108.34% | -295.09% | 49.97% | 221.97% |

## Balance Sheet (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 2.31B | 2.34B | 2.30B | 2.22B | 2.22B |
| Leverage | 1.06 | 1.08 | 1.08 | 1.07 | 1.09 |
| BVPS | 5.37 | 5.38 | 5.25 | 5.14 | 5.04 |
| Turnover | 0.6710 | 0.6427 | 0.6373 | 0.6220 | 0.7781 |
| Cash & STI | 1.13B | 1.42B | 1.39B | 1.43B | 396.33M |
| Inv & Rec | 135.00M | 132.32M | 183.63M | 118.57M | 123.43M |
| LT assets | 292.79M | 283.81M | 278.19M | 267.57M | 262.90M |
| Net debt | -1.13B | -1.42B | -1.38B | -1.43B | -393.21M |

## Cash Flow Statement (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 86.71M | 148.40M | -15.00M | 77.62M | 38.76M |
| Investing CF | -74.31M | 60.98M | -28.83M | -37.75M | -168.15M |
| Financing CF | -79.85M | -94.89M | -379766.00 | -62.68M | -379767.00 |
| Free CF | -249.45M | 88.45M | -65.62M | 1.28B | -1.25B |
| OCF coverage | 95.36% | 101.72% | -133.06% | 79.43% | 106.70% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -12.22M | -50.61M | -11.27M | -28.94M | -37.09M |

## Distribution Plan

**Dividend Yield**: 1.91

### Dividend History

| Description | Record Date | Ex-Date | Payment Date |
|-------------|-------------|---------|--------------|
| Cash Dividend: 
0.2CNY | 2025-09-17 | 2025-09-18 | 2025-09-18 |
| Cash Dividend: 
0.23CNY | 2025-05-29 | 2025-05-30 | 2025-05-30 |
| Cash Dividend: 
0.18CNY | 2024-10-29 | 2024-10-30 | 2024-10-30 |